Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C352085-100 100 µl (1 mg/ml) $299 
CXADR Antibody - Immunofluorescent analysis of CXADR staining in NIH3T3 cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
CXADR Antibody - Western blot analysis of CXADR expression in HeLa (A); NIH3T3 (B); H9C2 (C) whole cell lysates.
CXADR Antibody - Immunofluorescent analysis of CXADR staining in NIH3T3 cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
CXADR Antibody - Western blot analysis of CXADR expression in HeLa (A); NIH3T3 (B); H9C2 (C) whole cell lysates.
1 of 2
2 of 2

Polyclonal Rabbit anti‑Human CXADR Antibody (N‑Terminus, IF, WB) LS‑C352085

Polyclonal Rabbit anti‑Human CXADR Antibody (N‑Terminus, IF, WB) LS‑C352085

Antibody:
CXADR Rabbit anti-Human Polyclonal (N-Terminus) Antibody
Application:
ICC, IF, WB
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified
Price
Catalog Number
$299
LS-C352085-100
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
CXADR Rabbit anti-Human Polyclonal (N-Terminus) Antibody
Application:
ICC, IF, WB
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified

Specifications

Description
CXADR antibody LS-C352085 is an unconjugated rabbit polyclonal antibody to CXADR (N-Terminus) from human. It is reactive with human, mouse and rat. Validated for ICC, IF and WB.
Target
Human CXADR
Synonyms
CXADR | CAR4/6 | Coxsackie-adenovirus receptor | CVB3-binding protein | CAR | HCAR | HCVADR
Host
Rabbit
Reactivity
Human, Mouse, Rat (tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Modifications
Unmodified
Immunogen
KLH-conjugated synthetic peptide encompassing a sequence within the N-Terminus of human CXADR.
Epitope
N-Terminus
Specificity
Recognizes endogenous levels of CXADR protein.
Applications
  • ICC (1:100 - 1:500)
  • Immunofluorescence
  • Western blot (1:500 - 1:1000)
Presentation
PBS, pH 7.3, 0.01% Sodium Azide, 30% Glycerol
Storage
Store at -20°C. Aliquot to avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About CXADR
P78310 NM_001338 NP_001329.1

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 11/22/2024